ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
76 hedge funds and large institutions have $56.8M invested in Oncternal Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
44% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 18
Holders
76
Holding in Top 10
–
Calls
$1.86M
Puts
$882K
Top Buyers
| 1 | +$1.06M | |
| 2 | +$913K | |
| 3 | +$686K | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$683K |
| 5 |
Renaissance Technologies
New York
|
+$378K |
Top Sellers
| 1 | -$1.38M | |
| 2 | -$818K | |
| 3 | -$587K | |
| 4 |
ACA
Apis Capital Advisors
New York
|
-$570K |
| 5 |
Two Sigma Investments
New York
|
-$418K |